secwatch.observer — SEC 8-K summary
======================================

Issuer:     HeartSciences Inc. (HSCS)
CIK:        0001468492
Form:       8-K
Filed at:   2023-08-30T23:59:59+00:00
Accession:  0000950170-23-045465
Event type: regulatory
Sentiment:  positive
Materiality: 0.70
Item codes: 3.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Nasdaq panel grants Heart Test Labs continued listing with compliance deadlines
-------------------------------------------------------------------------------

- Hearing Panel granted continued listing on Nasdaq Capital Market subject to conditions.
- Company must demonstrate compliance with Equity Rule (minimum stockholders' equity) by Nov 21, 2023.
- Company has until Jan 29, 2024 to meet the $1 minimum bid price requirement.
- Previously received delist notice on June 20, 2023 for non-compliance with Equity Rule; appeal filed June 27.
- Also received bid price deficiency notice on Aug 1, 2023; separate condition for bid price compliance.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1468492/000095017023045465/0000950170-23-045465-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1468492/000095017023045465/hscs-20230828.htm
  HTML page:      https://secwatch.observer/filing/0000950170-23-045465

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer